Your browser doesn't support javascript.
loading
Enhanced perforin expression associated with dasatinib therapy in natural killer cells.
Iriyama, Noriyoshi; Takahashi, Hiromichi; Miura, Katsuhiro; Uchino, Yoshihito; Nakagawa, Masaru; Hatta, Yoshihiro; Takei, Masami.
Afiliação
  • Iriyama N; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan. Electronic address: iriyama.noriyoshi@nihon-u.ac.jp.
  • Takahashi H; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan; Division of Laboratory Medicine, Department of Pathology and Microbiology, Nihon University School of Medicine, Tokyo, Japan.
  • Miura K; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Uchino Y; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan. Electronic address: hatta.yoshihiro@nihon-u.ac.jp.
  • Nakagawa M; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Hatta Y; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
  • Takei M; Division of Hematology and Rheumatology, Department of Medicine, Nihon University School of Medicine, Tokyo, Japan.
Leuk Res ; 68: 1-8, 2018 05.
Article em En | MEDLINE | ID: mdl-29494851
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Perforina / Dasatinibe / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Células Matadoras Naturais / Leucemia Mielogênica Crônica BCR-ABL Positiva / Inibidores de Proteínas Quinases / Perforina / Dasatinibe / Antineoplásicos Tipo de estudo: Risk_factors_studies Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Revista: Leuk Res Ano de publicação: 2018 Tipo de documento: Article